Stockreport

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF First concentrated, ready-to-dilute liquid glucagon available for growing procedural gastroenterology marketAmerican Regent to commercialize GVOKE VialDx™Availability is [Read more]